Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Medical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Declines in unintended pregnancy in the United States, 2008-2011.N Engl J Med. 2016; 374 (PMID: 26962904; PMCID: PMC4861155): 843-852https://doi.org/10.1056/NEJMsa1506575
- One Key Question®: First Things First in Reproductive Health.Matern Child Health J. 2017; 21: 387-392https://doi.org/10.1007/s10995-017-2283-2
- Effects of clinic-level implementation of One Key Question® on reproductive health counseling and patient satisfaction.Contraception. 2021; 103: 6-12https://doi.org/10.1016/j.contraception.2020.10.018
- Effectiveness of long-acting reversible contraception.N Engl J Med. 2012; 366: 1998-2007
- Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project.Contraception. 2011; 84 (Epub 2011 Apr 27. PMID: 22018123; PMCID: PMC3505875): 493-498https://doi.org/10.1016/j.contraception.2011.03.001
- Committee opinion No. 670: immediate postpartum long-acting reversible contraception.Obstet Gynecol. 2016; 128 (PMID: 27454734): e32-e37https://doi.org/10.1097/AOG.0000000000001587
- Contraceptive efficacy and safety of 52mg LNG-IUS for up to 8 years: findings from the Mirena Extension Trial.Am J Obstet Gynecol. 2022; (XX:x.exex.ex [e-pub])https://doi.org/10.1016/j.ajog.2022.09.007
- Management of heavy menstrual bleeding on anticoagulation.Hematology Am Soc Hematol Educ Program. 2020; 2020 (PMID: 33275699; PMCID: PMC7727540): 533-537https://doi.org/10.1182/hematology.2020000138
- Intrauterine contraception.Semin Reprod Med. 2016; 34: 175-182
- Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.Am J Med. 2009; 122: 497-506
- U.S. selected practice recommendations for contraceptive use, 2016.MMWR Recomm Rep. 2016; 65 (PMID: 27467319): 1-66https://doi.org/10.15585/mmwr.rr6504a1
- (Available at:)
- Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review.Obstet Gynecol. 2019; 133: 332-341https://doi.org/10.1097/AOG.0000000000003089
- Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.Obstet Gynecol. 2011; 117: 793-797https://doi.org/10.1097/AOG.0b013e31820f387c
- Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.Obstet Gynecol. 2013; 121: 593-600
- Estetrol/drospirenone: a review in oral contraception.Drugs. 2022; 82 (Epub 2022 Jul 4. [Erratum appears in: Drugs. 2022 Aug;82(12):1341. PMID: 35781795; PMCID: PMC9363382]): 1117-1125https://doi.org/10.1007/s40265-022-01738-8
- Combination estrogen-progestin oral contraceptives.N Engl J Med. 2003; 349: 1443-1450
- Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case control study based on UK General Practice Research Database.BMJ. 2011; 342: d2139https://doi.org/10.1136/bmj.d2139
- U.S. Medical eligibility criteria for contraceptive use.MMWR Recomm Rep. 2016; 65: 1-104https://doi.org/10.15585/mmwr.rr6503a1
- The management of irregular bleeding in women using contraception.Aust Fam Physician. 2017; 46 (PMID: 29036769): 717-720
- New contraception update - Annovera, Phexxi, Slynd, and Twirla.Curr Obstet Gynecol Rep. 2022; 11 (Epub 2022 Jan 6. PMID: 35795653; PMCID: PMC9255890): 21-27https://doi.org/10.1007/s13669-021-00321-4
- Efficacy, safety, and personal considerations.in: Hatcher R.A. Nelson A.L. Trussell J. Contraceptive technology. 21st edition. Ayer Company Publishers, Inc., New York2018
- Practice bulletin No. 152: emergency contraception.Obstet Gynecol. 2015; 126 (PMID: 26287787): e1-e11https://doi.org/10.1097/AOG.0000000000001047
- Levonorgestrel vs. copper intrauterine devices for emergency contraception.N Engl J Med. 2021; 384 (PMID: 33503342; PMCID: PMC7983017): 335-344https://doi.org/10.1056/NEJMoa2022141
Article info
Publication history
Published online: December 27, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
